Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
57.21
-0.74 (-1.28%)
Mar 9, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 9.97 billion as of March 9, 2026. Its market cap has increased by 89.42% in one year.
Market Cap
9.97B
Enterprise Value
8.54B
Revenue
1.33B
Ranking
n/a
PE Ratio
35.10
Stock Price
57.21
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 9.97B, an increase of 11.16%. That is a compound annual growth rate of 1.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.37B |
| Chongqing Genrix Biopharmaceutical | 9.84B |
| Liaoning Chengda Biotechnology | 10.39B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.66B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| HitGen | 10.83B |
| Chengzhi | 10.85B |
| Bio-Thera Solutions | 9.37B |